CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.
about
Emerging adenosine receptor agonistsA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingThe anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cellsThe anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.Ginseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsCF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.Adenosine receptors and cancer.The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer.Neoplasia: An Anniversary of Progress.Polypharmacology of N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic PoThe combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma.A₃ receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway.
P2860
Q28249111-9A5AA561-6D3E-446D-927A-E3F2197FBFABQ28389391-056209B8-4307-483C-9C02-55F5A8DAABF5Q28395095-A578EC19-0699-4932-917C-FB566848907BQ28728011-D1789BF8-71D0-4263-BDB2-0060B8339A99Q31132502-DB306BCC-3CDC-4E00-A4B6-6F3DDA457CB2Q35511894-A9BD60C8-A7CD-4492-BE89-8FEFB761978FQ35788500-D07C4665-500C-465E-8722-2957EAFD5ACBQ36327138-0A91EAA2-853A-4926-A91A-B8BC725D044BQ37293340-59502977-49BF-487F-B093-E033AB38C782Q37565200-7DE62086-0C51-4863-97DB-68190E5BA442Q37957791-4BBE5BA3-2F83-4C7A-94E5-9F255DB13C94Q39375802-CE21049B-0340-4B72-84E0-96A864867BB3Q46932476-C4498670-13CD-40AF-94EF-669041E6FDE8Q47964767-8B5704B3-7416-4409-87C1-E256E3674820Q51063326-B51D8FF8-26D6-4915-8BF9-95BFBC5CAC5BQ54409505-267DF06B-42AA-4D4F-8888-59AA5BF38119
P2860
CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
CF101, an agonist to the A3 ad ...... colon carcinoma murine model.
@en
type
label
CF101, an agonist to the A3 ad ...... colon carcinoma murine model.
@en
prefLabel
CF101, an agonist to the A3 ad ...... colon carcinoma murine model.
@en
P2093
P2860
P356
P1433
P1476
CF101, an agonist to the A3 ad ...... colon carcinoma murine model.
@en
P2093
Daniel Silberman
Maya Shkapenuk
Sara Bar-Yehuda
Slosman Gery
P2860
P356
10.1593/NEO.04364
P577
2005-01-01T00:00:00Z